NEW YORK--(BUSINESS WIRE)--Cell Signaling Technology, Inc. (CST), a worldwide provider of antibodies, announced today the release of a first to market, IHC-approved, human-specific, VISTA rabbit monoclonal antibody (mAb), for use in biomedical research. This announcement was made at the CRI-CIMT-EATI-AACR Inaugural International Cancer Immunotherapy Conference: Translating Science into Survival, September 16-19, 2015 in New York, NY.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
